PURIFIED CYTOKINE INHIBITORY FACTOR
Application 1090/KOLNP/2004 published 2006-07-14, filed 2004-07-29
Disclosed is a composition comprising a substantially purified Cytokine Inhibitory Factor (CIF) having certain characteristics, including the ability to inhibit RNA transcription of the pro-inflammatory cytokines tumor necrosis factor alpha (TNF-. LQWHUOHXNLQ-beta (IL- DQGLQWHUOHXNLQ-2 (IL-2). Also disclosed is a method for substantially purifying the Cytokine Inhibitory Factor and a method for modulating the immune system of an animal using such composition (FIG. nil)
Applicant
ARKION LIFE SCIENCES LLC.
3521 SILVERSIDE ROAD, QUILLEN BUILDING, WILMINGTON, DE 19810, U.S.A
Inventor
(1) IYER, SUBRAMANIAN (2) JOHNSON, WILLIAM L. (3) NGUYEN, LANCE (4) ROSS, STEVEN C. (5) XING, RUYE
International Info
Classification: A61K 35/54
Publication Number: WO03/068152A3-21.08.2003
Application Date: 2003-02-11
Priority Information
60/356,038 U.S.A 2002-02-11
10/364,593 U.S.A 2003-02-11